72.73
price up icon3.87%   2.71
after-market After Hours: 74.68 1.95 +2.68%
loading
Praxis Precision Medicines Inc stock is traded at $72.73, with a volume of 137.50K. It is up +3.87% in the last 24 hours and up +12.00% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
See More
Previous Close:
$70.02
Open:
$70.02
24h Volume:
137.50K
Relative Volume:
0.55
Market Cap:
$1.27B
Revenue:
-
Net Income/Loss:
$-123.28M
P/E Ratio:
-24.00
EPS:
-3.03
Net Cash Flow:
$-111.14M
1W Performance:
+2.39%
1M Performance:
+12.00%
6M Performance:
+33.35%
1Y Performance:
+6,394%
1-Day Range:
Value
$69.20
$72.84
1-Week Range:
Value
$67.36
$72.84
52-Week Range:
Value
$0.867
$75.73

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
Name
Praxis Precision Medicines Inc
Name
Phone
617-300-8460
Name
Address
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
Employee
82
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PRAX's Discussions on Twitter

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-19-23 Initiated Truist Buy
Jun-06-22 Downgrade Wedbush Outperform → Neutral
Dec-16-21 Initiated H.C. Wainwright Buy
Aug-26-21 Initiated BofA Securities Buy
Apr-26-21 Initiated William Blair Outperform
Nov-11-20 Initiated Wedbush Outperform
Nov-10-20 Initiated Cowen Outperform
Nov-10-20 Initiated Evercore ISI Outperform
Nov-10-20 Initiated Piper Sandler Overweight
View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

pulisher
03:44 AM

Vanguard Group Inc's Strategic Acquisition in Praxis Precision M - GuruFocus.com

03:44 AM
pulisher
Nov 03, 2024

Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - StockTitan

Nov 01, 2024
pulisher
Oct 26, 2024

(PRAX) Trading Advice - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 24, 2024

Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 24, 2024
pulisher
Oct 21, 2024

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 21, 2024
pulisher
Oct 16, 2024

Praxis Precision To Report Aria Study Data In June - RTTNews

Oct 16, 2024
pulisher
Oct 16, 2024

Will Praxis Precision Hit The Targets? - RTTNews

Oct 16, 2024
pulisher
Oct 15, 2024

Praxis Precision Medicines revises executive severance terms - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Where are the Opportunities in (PRAX) - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews

Oct 15, 2024
pulisher
Oct 15, 2024

Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India

Oct 14, 2024
pulisher
Oct 14, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

Praxis stock soars to 52-week high, hits $68 amid robust gains - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Millennium Management LLC - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Praxis Precision Medicines: Great Price Movement, But Still Not Convinced (NASDAQ:PRAX) - Seeking Alpha

Oct 13, 2024
pulisher
Oct 12, 2024

Praxis Precision Medicines, Inc (PRAX): A Small-Cap Leader in Biopharmaceuticals - Insider Monkey

Oct 12, 2024
pulisher
Oct 11, 2024

The Manufacturers Life Insurance Company Buys 15,443 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 11, 2024
pulisher
Oct 09, 2024

Praxis Precision Medicines Sees Unusually Large Options Volume (NASDAQ:PRAX) - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

10 Small Cap Stocks with High Potential - Insider Monkey

Oct 07, 2024
pulisher
Oct 06, 2024

Praxis Precision Medicines (PRAX) Moves 8.4% Higher: Will This Strength Last? - MSN

Oct 06, 2024
pulisher
Oct 04, 2024

(PRAX) Investment Analysis and Advice - Stock Traders Daily

Oct 04, 2024
pulisher
Oct 04, 2024

PRAX Stock: Exploring Praxis Precision Medicines Inc’s Growth - The InvestChronicle

Oct 04, 2024
pulisher
Oct 03, 2024

Praxis stock soars to 52-week high, hits $67.36 amid robust gains By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Praxis stock soars to 52-week high, hits $67.36 amid robust gains - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Truist maintains Buy rating on Praxis shares By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Noteworthy Thursday Option Activity: PRAX, CVNA, AMPY - Nasdaq

Oct 03, 2024
pulisher
Oct 03, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 2.3% - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 3.6% - MarketBeat

Oct 02, 2024
pulisher
Sep 30, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Perceptive Advisors LLC - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Marshall Wace LLP Boosts Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 29, 2024
pulisher
Sep 28, 2024

Fred Alger Management LLC Has $107,000 Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

Praxis Precision Medicines presents on ulixacaltamide - GlobeNewswire

Sep 26, 2024
pulisher
Sep 26, 2024

Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International Congress - StockTitan

Sep 26, 2024
pulisher
Sep 26, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Point72 Asset Management L.P. Grows Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 26, 2024
pulisher
Sep 24, 2024

Rhumbline Advisers Grows Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Ally Bridge Group NY LLC Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Tri Locum Partners LP Sells 31,175 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 23, 2024
pulisher
Sep 18, 2024

Praxis Precision’s relutrigine reduces seizures in rare epileptic disorders in phase 2 clinical trials - 2 Minute Medicine

Sep 18, 2024
pulisher
Sep 18, 2024

49,510 Shares in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Bought by Bank of New York Mellon Corp - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 2.5% - MarketBeat

Sep 18, 2024
pulisher
Sep 14, 2024

TD Asset Management Inc Increases Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Sep 14, 2024
pulisher
Sep 14, 2024

TD Asset Management Inc Grows Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Sep 14, 2024

Praxis Precision Medicines Inc Stock (PRAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):